Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

NCT02784561 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Busulfan (Zhejiang Otsuka Pharmaceutical Co. Ltd)
DRUG: Cytarabine(Actavis Italy S.p.A)
DRUG: Fludarabine (Bayer)
DRUG: granulocyte colony-stimulating factor (KirinKunpeng)
DRUG: rabbit ATG（Sanofi/Genzyme）

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]
[object Object]